Wayne Kuznar
Side effects of modern PCa treatments compared
Despite technological advances in treatment for localized prostate cancer, men continue to experience clinically meaningful side effects that affect quality of life, according to an examination of data from a prospective population-based cohort study.
Higher reclassification rate seen with saturation biopsy
Transrectal saturation biopsy resulted in higher rates of disease reclassification compared with magnetic resonance (MR) fusion biopsy plus extended sextant prostate biopsy in patients with low-risk prostate cancer on active surveillance.
Bx-related complications influence decision-making
Bx-related complications influence decision-making
Men who experience a prostate biopsy-related complication are more likely to seek active treatment for clinically localized prostate cancer than those who do not experience a complication, according to findings from a review of the Surveillance, Epidemiology, and End Results Medicare linked database.
Metastatic PCa: Studies point to new standard of care
“Abiraterone should change the treatment paradigm for patients with newly diagnosed metastatic prostate cancer and largely displaces chemotherapy from the current paradigm,” said Sumanta Kumar Pal, MD.
Delayed RP does not raise adverse pathology risk
Delayed RP does not raise adverse pathology risk
Men with prostate cancer who meet the criteria for active surveillance and undergo delayed radical prostatectomy after a period of active surveillance do not have a higher risk of adverse pathology compared with men with similar pre-treatment biopsy features who undergo immediate prostatectomy.
Anti-VEGF therapy superior to laser for preventing recurrences of retinopathy in prematurity
Intravitreal injection of bevacizumab proved superior to conventional laser therapy for preventing recurrence of retinopathy of prematurity while averting many of the complications of laser treatment.
  • 1
  • 2